Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy
{{output}}
Meningiomas are the most common primary tumor in the central nervous system, yet an effective systemic treatment remains a challenge. We present a grade 2 meningioma that resulted in a positive and prolonged response to pembrolizumab. Our case had polybromo-1 ... ...